Related Experiment Video

Updated: Nov 26, 2025

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
09:20

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

Published on: May 4, 2021

4.0K

The Inhibitory Effects of Juglanin on Adipogenesis in 3T3-L1 Adipocytes

Guang Wang1, Bing Wu2, Wenzhou Xu3

  • 1Department of Intensive Care Unit, The First Hospital of Jilin University, Changchun, Jilin 130033, People's Republic of China.

Drug Design, Development and Therapy
|December 9, 2020
PubMed
Abstract

Insights

Juglanin, a natural flavonoid, effectively inhibits adipogenesis by reducing lipid accumulation and key gene expression. Its mechanism involves activating the SIRT1/AMPK pathway, suggesting potential for obesity and metabolic disorder treatments.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Metabolic Research

Background:

  • Adipogenesis deregulation is linked to obesity and metabolic disorders.
  • Key transcription factors like PPAR, C/EBP, and SREBP1c regulate adipogenesis.
  • Juglanin, a flavonoid, shows anti-inflammatory and anti-cancer properties, but its role in adipogenesis is unexplored.

Purpose of the Study:

  • To investigate the effects of juglanin on adipogenesis in 3T3-L1 preadipocytes.
  • To elucidate the molecular mechanisms underlying juglanin's action on adipogenesis.

Main Methods:

  • 3T3-L1 preadipocytes were treated with varying concentrations of juglanin during differentiation.
  • Lipid accumulation was quantified using Oil Red O staining.
  • Gene and protein expression of adipogenesis-related factors were analyzed via real-time PCR and Western blot.
  • The role of the AMPK pathway was assessed using an AMPK inhibitor.

Main Results:

  • Juglanin significantly reduced lipid droplet accumulation in differentiated adipocytes.
  • Juglanin suppressed the expression of C/EBPα, C/EBPβ, and SREBP-1c, but not PPARα or PPARγ.
  • Juglanin promoted the activation of the SIRT1/AMPK signaling pathway.
  • Inhibiting AMPK abolished the anti-adipogenic effects of juglanin.

Conclusions:

  • Juglanin effectively prevents adipogenesis by inhibiting lipid accumulation and preadipocyte differentiation.
  • The anti-adipogenic effects of juglanin are mediated through the SIRT1/AMPK signaling pathway.
  • Further in vivo and clinical studies are warranted to explore juglanin's therapeutic potential for obesity and metabolic disorders.
Keywords:
AMPKJuglaninadipogenesislipid metabolismobesity

More Related Videos

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro09:41

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Published on: March 17, 2023

3.3K
Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance09:48

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance

Published on: February 17, 2023

3.2K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.3K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
382
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.6K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.5K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.8K